ORPEYGO

Serial Number 90731481
606

Registration Progress

Application Filed
May 24, 2021
Under Examination
Feb 14, 2023
Approved for Publication
Dec 20, 2022
Published for Opposition
Dec 20, 2022
Registered

Trademark Image

ORPEYGO

Basic Information

Serial Number
90731481
Filing Date
May 24, 2021
Published for Opposition
December 20, 2022
Abandonment Date
March 18, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 18, 2024
Classes
005

Rights Holder

Calliditas Therapeutics AB

99
Address
PO Box 70351
Stockholm SE-10724
SE

Ownership History

Calliditas Therapeutics AB

Original Applicant
99
Stockholm SE

Calliditas Therapeutics AB

Owner at Publication
99
Stockholm SE

Legal Representation

Attorney
Pam Kohli Jacobson

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description
Mar 18, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 18, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 1, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 1, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 1, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 11, 2023 EX1G S SOU EXTENSION 1 GRANTED
Aug 11, 2023 EXT1 S SOU EXTENSION 1 FILED
Aug 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 PUBO A PUBLISHED FOR OPPOSITION
Nov 30, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 22, 2022 GNRT O NON-FINAL ACTION E-MAILED
Aug 22, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 2, 2022 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 14, 2022 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 1, 2022 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
May 27, 2022 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 21, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2022 ALIE A ASSIGNED TO LIE
Apr 18, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2022 GNRT F NON-FINAL ACTION E-MAILED
Feb 12, 2022 CNRT R NON-FINAL ACTION WRITTEN
Feb 3, 2022 DOCK D ASSIGNED TO EXAMINER
Aug 19, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medical and pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Diagnostic preparations and materials in the nature of companion diagnostics kits comprising medical diagnostic reagents and also including tubes, microtiterplates, diluents, vials, kit instructions, pipetting tools and devices, containers, and packaging materials; and, kits comprising reagents for diagnosis and prognosis for medical purposes and also including tubes, microtiterplates, diluents, vials, kit instructions, pipetting tools and devices, containers, packaging materials and; Pharmaceutical and natural remedy preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Pharmaceutical drugs for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...